CONTRASTING EFFECTS OF LOVASTATIN AND CHOLESTYRAMINE ON LOW-DENSITY LIPOPROTEIN CHOLESTEROL AND 24-HOUR URINARY MEVALONATE EXCRETION IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA

被引：0
|
作者：
PAPPU, AS [1 ]
ILLINGWORTH, DR [1 ]
机构：
[1] OREGON HLTH SCI UNIV, DEPT MED, DIV ENDOCRINOL METAB & CLIN NUTR, L465, PORTLAND, OR 97201 USA
来源：
JOURNAL OF LABORATORY AND CLINICAL MEDICINE | 1989年 / 114卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：554 / 562
页数：9
相关论文
共 50 条
  • [1] REDUCTION IN PLASMA LOW-DENSITY LIPOPROTEIN CHOLESTEROL AND URINARY MEVALONIC ACID BY LOVASTATIN IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    PAPPU, AS
    ILLINGWORTH, DR
    BACON, S
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1989, 38 (06): : 542 - 549
  • [2] CONTRASTING EFFECTS OF LOVASTATIN (MEVINOLIN) AND BILE-ACID SEQUESTRANTS ON 24 HOUR URINARY MEVALONATE IN FAMILIAL HYPERCHOLESTEROLEMIA
    PAPPU, AS
    ILLINGWORTH, DR
    ARTERIOSCLEROSIS, 1987, 7 (05): : A513 - A513
  • [3] THE INFLUENCE OF LOVASTATIN (MEVINOLIN) ON 24 HOUR URINARY MEVALONATE IN FAMILIAL HYPERCHOLESTEROLEMIA
    PAPPU, AS
    BACON, SP
    ILLINGWORTH, DR
    CLINICAL RESEARCH, 1987, 35 (03): : A625 - A625
  • [4] Effects of colestimide in addition to atorvastatin on low-density lipoprotein (LDL) cholesterol in patients with heterozygous familial hypercholesterolemia (FH)
    Kawashiri, M
    Higashikata, T
    Tsuchida, M
    Takata, M
    Katsuda, S
    Miwa, K
    Inazu, A
    Mabuchi, H
    ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 172 - 172
  • [5] Low-Density Lipoprotein Cholesterol Trajectories and Prevalence of High Low-Density Lipoprotein Cholesterol Consistent With Heterozygous Familial Hypercholesterolemia in US Children
    Zhang, Yiyi
    Woo, Jessica G.
    Urbina, Elaine M.
    Jacobs, David R., Jr.
    Moran, Andrew E.
    de Ferranti, Sarah D.
    JAMA PEDIATRICS, 2021, 175 (10) : 1071 - 1074
  • [6] Attainment of the low-density lipoprotein cholesterol treatment target and prognosis of heterozygous familial hypercholesterolemia
    Tada, Hayato
    Nomura, Akihiro
    Nohara, Atsushi
    Usui, Soichiro
    Sakata, Kenji
    Hayashi, Kenshi
    Fujino, Noboru
    Takamura, Masayuki
    Kawashiri, Masa-aki
    ATHEROSCLEROSIS, 2023, 371 : 61 - 66
  • [7] Attainment of the low-density lipoprotein cholesterol treatment target and prognosis of heterozygous familial hypercholesterolemia
    Tada, H.
    Nomura, A.
    Usui, S.
    Sakata, K.
    Takamura, M.
    Kawashiri, M.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [8] EFFECTS OF FENOFIBRATE ON HIGH AND LOW-DENSITY LIPOPROTEIN METABOLISM IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    MALMENDIER, CL
    DELCROIX, C
    ATHEROSCLEROSIS, 1985, 55 (02) : 161 - 169
  • [9] Clinical Impact of Lipoprotein (a) and Cumulative Low-Density Lipoprotein Cholesterol Exposure on Coronary Artery Disease in Patients with Heterozygous Familial Hypercholesterolemia
    Shishikura, Daisuke
    Harada-Shiba, Mariko
    Michikura, Masahito
    Fujioka, Shimpei
    Fujisaka, Tomohiro
    Morita, Hideaki
    Kanzaki, Yumiko
    Hoshiga, Masaaki
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2025, 32 (01) : 100 - 110
  • [10] Effects of statin on small dense low-density lipoprotein cholesterol and remnant-like particle cholesterol in heterozygous familial hypercholesterolemia
    Nozue, Tsuyoshi
    Michishita, Lchiro
    Ito, Yasuki
    Hirano, Tsutomu
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2008, 15 (03) : 146 - 153
12345